gynecology
The Bill & Melinda Gates Foundation accelerates research and innovation targeting the most neglected areas of female health.
Women with lower DI-GM scores showed a higher risk of infertility, highlighting the potential importance of gut microbiota diversity as a factor in female reproductive health.
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.
Mice born to mothers exposed to Akkermansia muciniphila during pregnancy showed improvements in stem cell activity.
The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.
A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.
A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).
